指南与共识类风湿关节炎脊柱关节炎

2019 ACR/AF 幼年特发性关节炎治疗指南:非系统性多关节炎、骶髂关节炎及附着点炎

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.
指南 / 共识 · Arthritis Rheumatol · 2019-04-25

该指南针对幼年特发性关节炎表现为非系统性多关节炎、骶髂关节炎或附着点炎的患儿制定治疗推荐。推荐涵盖 NSAIDs、DMARDs、生物制剂、关节腔及口服糖皮质激素以及物理/作业治疗,强调达标治疗和共享决策。

要点

  • 90% 推荐的支持证据质量极低或低。
  • 多关节炎推荐强调良好疾病控制,并通过治疗升级达到低疾病活动度。

核心结论

  • 该指南为临床医生、照护者和患者做出治疗决策提供方向,推荐采用共享决策并考虑患者价值观、偏好和合并症。
  • 这些推荐不应被用于限制或拒绝患者获得治疗。

研究设计与样本

  • 由指南制定团队成员开发并细化 PICO 问题,系统综述汇总治疗获益与危害证据。
  • 采用 GRADE 方法评定证据质量,投票小组通过共识流程生成最终推荐并评定强度。
  • 家长和患者小组采用类似共识方法提供患者/照护者对关键问题的偏好。

主要发现

  • 推荐涉及 NSAIDs、DMARDs、生物制剂、关节腔及口服糖皮质激素的使用。
  • 还提供了物理治疗和作业治疗的使用推荐。
  • 多关节炎的具体推荐涉及一般药物使用、初始及后续治疗和辅助治疗,推荐良好疾病控制并通过治疗升级达到低疾病活动度。
  • 骶髂关节炎和附着点炎推荐主要涉及初始治疗和辅助治疗。

关键数值与推荐

  • 90% 推荐的支持证据质量极低或低。

临床怎么用

  • 临床医生、照护者和患者应使用共享决策流程,考虑患者的价值观、偏好和合并症。
  • 多关节炎治疗应以良好疾病控制为目标,通过治疗升级达到低疾病活动度。
  • 推荐不应被用于限制或拒绝患者获得治疗。

局限性

  • 90% 推荐的支持证据质量极低或低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To develop treatment recommendations for children with juvenile idiopathic arthritis manifesting as non-systemic polyarthritis, sacroiliitis, or enthesitis. METHODS: The Patient/Population, Intervention, Comparison, and Outcomes (PICO) questions were developed and refined by members of the guideline development teams. A systematic review was conducted to compile evidence for the benefits and harms associated with treatments for these conditions. GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology was used to rate the quality of evidence. A group consensus process was conducted among the Voting Panel to generate the final recommendations and grade their strength. A Parent and Patient Panel used a similar consensus approach to provide patient/caregiver preferences for key questions. RESULTS: Thirty-nine recommendations were developed (8 strong and 31 conditional). The quality of supporting evidence was very low or low for 90% of the recommendations. Recommendations are provided for the use of nonsteroidal antiinflammatory drugs, disease-modifying antirheumatic drugs, biologics, and intraarticular and oral glucocorticoids. Recommendations for the use of physical and occupational therapy are also provided. Specific recommendations for polyarthritis address general medication use, initial and subsequent treatment, and adjunctive therapies. Good disease control, with therapeutic escalation to achieve low disease activity, was recommended. The sacroiliitis and enthesitis recommendations primarily address initial therapy and adjunctive therapies. CONCLUSION: This guideline provides direction for clinicians, caregivers, and patients making treatment decisions. Clinicians, caregivers, and patients should use a shared decision-making process that accounts for patients' values, preferences, and comorbidities. These recommendations should not be used to limit or deny access to therapies.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Ringold S, Angeles-Han ST, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Arthritis Rheumatol. 2019. PMID: 31021537. doi:10.1002/art.40884

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。